199 related articles for article (PubMed ID: 36864014)
1. Assessing non-adjunctive CGM safety at home and in new markets (ANSHIN).
Chao C; Andrade SB; Bergford S; Calhoun P; Welsh JB; Walker TC;
Endocrinol Diabetes Metab; 2023 May; 6(3):e414. PubMed ID: 36864014
[TBL] [Abstract][Full Text] [Related]
2. Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study.
Gilbert TR; Noar A; Blalock O; Polonsky WH
Diabetes Technol Ther; 2021 Mar; 23(S1):S35-S39. PubMed ID: 33470882
[No Abstract] [Full Text] [Related]
3. Non-adjunctive continuous glucose monitoring for control of hypoglycaemia (COACH): Results of a post-approval observational study.
Beck SE; Kelly C; Price DA;
Diabet Med; 2022 Feb; 39(2):e14739. PubMed ID: 34758142
[TBL] [Abstract][Full Text] [Related]
4. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
[TBL] [Abstract][Full Text] [Related]
5. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.
Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ
Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743
[TBL] [Abstract][Full Text] [Related]
6. Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial.
Reed J; Dong T; Eaton E; Friswold J; Porges J; Al-Kindi SG; Rajagopalan S; Neeland IJ
Diabetes Obes Metab; 2024 Jul; 26(7):2881-2889. PubMed ID: 38680050
[TBL] [Abstract][Full Text] [Related]
7. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
[TBL] [Abstract][Full Text] [Related]
8. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
[TBL] [Abstract][Full Text] [Related]
9. The Optimal Duration of a Run-In Period to Initiate Continuous Glucose Monitoring for a Randomized Trial.
Raghinaru D; Calhoun P; Bergenstal RM; Beck RW
Diabetes Technol Ther; 2022 Dec; 24(12):868-872. PubMed ID: 35920822
[No Abstract] [Full Text] [Related]
10. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; KrÓ§ger J; Weitgasser R; Bolinder J
Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
[TBL] [Abstract][Full Text] [Related]
11. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
[TBL] [Abstract][Full Text] [Related]
12. Initiation of Continuous Glucose Monitoring Is Linked to Improved Glycemic Control and Fewer Clinical Events in Type 1 and Type 2 Diabetes in the Veterans Health Administration.
Reaven PD; Newell M; Rivas S; Zhou X; Norman GJ; Zhou JJ
Diabetes Care; 2023 Apr; 46(4):854-863. PubMed ID: 36807492
[TBL] [Abstract][Full Text] [Related]
13. Reduction of clinically important low glucose excursions with a long-term implantable continuous glucose monitoring system in adults with type 1 diabetes prone to hypoglycaemia: the France Adoption Randomized Clinical Trial.
Renard E; Riveline JP; Hanaire H; Guerci B;
Diabetes Obes Metab; 2022 May; 24(5):859-867. PubMed ID: 34984786
[TBL] [Abstract][Full Text] [Related]
14. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
Rodbard D
Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
[TBL] [Abstract][Full Text] [Related]
15. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
Reddy M; Jugnee N; Anantharaja S; Oliver N
Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
[TBL] [Abstract][Full Text] [Related]
16. Improvement of metabolic control after 3-month use of real-time continuous glucose monitoring in patients with type 1 diabetes: a multicenter study in Greece.
Eleftheriadou I; Didangelos T; Pappas AC; Anastasiou E; Vasilopoulos C; Zoupas C; Manes C; Tsatsoulis A; Benroubi M; Pangalos E; Thomakos P; Gerasimidi-Vazeou A; Tentolouris N
Hormones (Athens); 2019 Dec; 18(4):443-450. PubMed ID: 31721132
[TBL] [Abstract][Full Text] [Related]
17. Real-world outcomes of continuous glucose monitoring in adults with diabetes mellitus attending an Irish tertiary hospital.
Courtney A; Smith D; Forde H
Ir J Med Sci; 2023 Dec; 192(6):2763-2768. PubMed ID: 36940009
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
[TBL] [Abstract][Full Text] [Related]
19. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry.
Wong JC; Foster NC; Maahs DM; Raghinaru D; Bergenstal RM; Ahmann AJ; Peters AL; Bode BW; Aleppo G; Hirsch IB; Kleis L; Chase HP; DuBose SN; Miller KM; Beck RW; Adi S;
Diabetes Care; 2014 Oct; 37(10):2702-9. PubMed ID: 25011947
[TBL] [Abstract][Full Text] [Related]
20. Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial - study protocol.
Beunen K; Van Wilder N; Ballaux D; Vanhaverbeke G; Taes Y; Aers XP; Nobels F; Marlier J; Lee D; Cuypers J; Preumont V; Siegelaar SE; Painter RC; Laenen A; Gillard P; Mathieu C; Benhalima K
BMC Pregnancy Childbirth; 2023 Mar; 23(1):180. PubMed ID: 36927458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
